A pproximately 6 million``dually-eligible'' patients in the United States receive both Medicare and Medicaid benefits. This group consumes 30% of the Medicare budget and 35% of Medicaid expenditures, while representing only 17% of the 37 million Medicare beneficiaries and 16% of the Medicaid population. 1 With the number of elderly Americans expected to double to approximately 70 million by 2030, and the number of frail elderly increasing at an even faster rate, providers are searching for ways to improve patients' health outcomes while containing costs. 2 In the last 10 years, many health plans have begun to focus on identifying those at greatest risk of poor outcomes with the goal of intervening to prevent or slow clinical deterioration. Since its publication in 1993, the Probability of Repeat Admission Questionnaire (Pra) has become a cornerstone of these efforts (available at www.blackwellscience.com/ jgi). This 8-question survey, which yields a risk score between 0.07 and 0.80, has been found valid and acceptable in many different populations of communitydwelling elderly, including Medicaid, fee-for-service, and managed care patients.
3±5
The Pra, however, has several drawbacks. First, although one of its putative strengths has been ease of administration, in published studies it generally achieves response rates of only 50% to 60%. 6±8 Second, those who do not respond to health surveys are often older and sicker than respondents, 9, 10 and as a result, these survey-based screening efforts may be missing those who would benefit most from targeted interventions. Third, the Medicaid population can represent an even more challenging group. Transiency and lower levels of literacy, for example, can lead to even lower response rates. 
METHODS

Setting
We selected 558 members of Health Partners of Philadelphia (a Medicaid HMO) who met the following criteria: age 65 years or older, continuous membership of Health Partners for 18 months (12 months prior to the survey and 6 months after), and dual-eligible Medicare/ Medicaid recipients ( Figure 1 ). The Institutional Review Board of the University of Pennsylvania and the HMO approved the study. Continuous membership was required in order to mirror the two longitudinal questions on the survey Pra: number of doctors visits and hospitalizations over the previous year.
Survey
Between October and November 1998, all 558 subjects received the survey Pra. Nonrespondents received a second questionnaire and finally a phone call encouraging them to participate in the health screening. Survey Pra scores were calculated as described by Pacala et al. 14 
Creation of the Administrative Proxy
The administrative proxy consisted of 7 of the 8 survey Pra items as shown in Table 1 . Following Coleman et al.'s methods, we dropped the item pertaining to patient support system. 15 The remaining items were extracted from four different Health Partners' databases including a general demographics database that contains basic demographic information as well as enrollment status, an inpatient claims database that contains all hospital and laboratory information as well as visits to specialists, an encounters database that encompasses primary care physician visits, and a pharmaceutical database. The combinations of databases used to create each item are also delineated in Table 1 . During the study period, primary care physicians received capitated payments from Health Partners; however, they were required to complete encounter forms and reimbursed $0.50 per form. Administrative databases generally capture simple demographic items and billing-related claims with high degrees of accuracy. 16, 17 We assigned diagnoses of diabetes or heart disease based on the presence of an appropriate International Classification of Diseases, 9th revision (ICD-9) code in the claims or encounter databases. The specific ICD-9 codes are detailed in Table 2 . Two or more instances were required to establish a diagnosis of diabetes or heart disease. 18 In addition, we assigned a diagnosis of diabetes to patients receiving more than one month's supply of oral hypoglycemic or insulin-based drugs, and a diagnosis of coronary artery disease for patients receiving multiple months of nitroglycerin-containing compounds (see Table 2 ). Finally, we used the Deyo-Charlson comorbidity index as a proxy for self-rated health status. This index is an ICD-9-based version of the well-known Charlson comorbidity index and has been shown to correlate strongly with patient-reported health. 19, 20 As in the Charlson index, the Deyo modification assigns comorbidity points based on the presence of clinical conditions (as defined by presence of ICD-9 codes), such as congestive heart failure and renal disease. These points are then totaled to yield an overall comorbidity score. We assigned Deyo scores of``0'' a proxy response of``excellent,''``1 ± 2'' a response of``fair,'' and``3 ± 4'' a response of``poor.'' Using the coefficients derived by Coleman et al. for scoring the administrative proxy, we calculated scores for the 558 patients. This yielded scores between 0.15 and 0.83, similar to the survey Pra. Our outcome of interest was total claims costs over the 6 months' follow-up from July 1, 1998, to December 31, 1998. These data were extracted from the claims database with the exception of drug costs that were extracted from the pharmacy database. We took the perspective of the health plan in calculating costs as the actual dollars paid by the HMO. We then defined high-cost patients as those in the top quartile of total costs to the health plan.
We used logistic regression to test for differences in the age, gender, and costs for respondents and nonrespondents. We used statistics to test the relationship between individual items on the survey Pra and administrative proxy, and then compared the sensitivity and specificity of each instrument at cut points from 0.40 to the traditional 0.50 to determine the optimal cut point for identifying high-cost patients. We then calculated total costs for groups designated as``high risk'' and``low risk'' based on cut point and used logistic regression to test for differences in costs between the two groups. To explore differences in patients identified as high risk by each scale, we divided patients into four groups:``concordant low risk'' (both scales rating a patient as low risk); discordant``administrative proxy only high risk''; discordant``survey Pra only high risk''; and concordant high risk (both scales rating a patient as high risk). We used nonparametric Kruskal-Wallis tests to test for overall cost differences among the groups and then to compare differences between individual groups correcting for multiple comparisons. To further explore the predictive accuracy of the survey Pra and administrative proxy for total costs, we then used logistic regression to compare scale risk scores to actual outcomes (high or low total cost groups). We measured areas under receiver operating characteristic curves (AUCs) to quantify this discriminative ability. An AUC of 0.5 represents discriminative capacity no greater than pure chance, and a value of 1.0 represents perfect predictive accuracy. After testing the administrative proxy in the respondent population, we tested its predictive ability in the nonrespondent population.
We used STATA version 5.0 (Stata Corp., College Station, Tex) for all statistical calculations except for AUC analyses for which we used the statistical program ROCKIT. 21 
RESULTS
Overall, response rate for the survey Pra was 54%. Respondents and nonrespondents did not differ significantly in age (71.1 years vs 71.7 years, P = .20); gender (24% male vs 28% male, P = .22); and total costs during follow-up ($2,106 vs $1,538, P = .07). Comparison of survey Pra scores to administrative proxy scores showed a correlation of 0.53, and distribution of these scales is shown in Figure 2 . Comparison of self-report to database responses for items yielded a of 0.75 or better for age, gender, hospitalization and diabetes, and kappas of 0.37 and 0.17 for heart disease and number of doctor visits respectively (Table 3) . Comparison of the indices' sensitivities and specificities at cut points from 0.40 to 0.50 are shown in Table 4 . Because the intent of these indices is to screen for high-cost patients, we chose the cut point with the maximum sensitivity as the cutoff for predicted highcost patients. The cost of false positives and false negatives is not available and therefore was not considered for this analysis.
Based on the chosen cut point of 0.40, the``high risk group'' of respondents utilized 2.7 times as many resources as the``low risk group'' ($3,844 vs $1,417, P = .00) based on survey Pra stratification, and 2.3 times as much resource use ($3,212 vs $1,377, P = .00) based on administrative proxy scoring. AUCs testing for the ability of each index to predict patient in the top quartile of total costs were 0.68 (95% confidence interval [CI] 0.64 to 0.72). The survey Pra and administrative proxy agreed on the classification of 216 of 296 patients; 169 were low risk by both scales, and 49 were high risk by both scales. Overall was 0.37. Resource use was lowest among patients identified as low risk by both scales ($1,176), highest among those identified as high risk by both scales ($4,359), and intermediate for those patients for whom the indices differed (Table 5 ). Kruskal-Wallis testing for differences across all groups was significant ( 2 57.7, probability > 2 = .0001); and pairwise comparisons of total costs by group were significant except for comparisons between the two discordant groups, and the``highrisk survey Pra only'' group versus the``concordant highrisk'' group. Finally, application of the administrative proxy to survey nonrespondents demonstrated stability in the index's performance. High-risk patients experienced total costs 2.1 times (P = .00) that of low-risk patients, and the AUC for the model was 0.67 (95% CI, 0.63 to 0.71).
DISCUSSION
The development of an administrative version of the Pra by Coleman et al. advanced our ability to identify the frail elderly. In this study, we sought to extend this work to a particularly vulnerable population of dual-eligible Medicare/Medicaid members with the goal of identifying patients at higher risk for significant resource utilization in the ensuing 6 months.
Of the 558 Health Partners members eligible for the study, 296 responded to the survey Pra. This 54% response rate was consistent with the response rates in other published studies of the Pra. 22±25 In this group of dualeligible patients, the survey Pra appeared to work as effectively as in other populations. Resource utilization was at least double across all groups tested, and overall AUCs were 0.67 to 0.68. Interestingly, respondents tended towards being sicker than nonrespondents, averaging $477 more in costs. This study has several limitations. First, using resource utilization as the metric to identify high-risk elders may not be ideal. Although costs are a readily measurable outcome of strategic importance for the ongoing operations of health plans, an ideal screening tool would also identify enrollees at risk for functional decline, and allow risk stratification and targeting of an appropriate level of intervention. Although Coleman et al. did validate the Pra against a measure of functional decline (restricted activity days), further research is clearly needed to evaluate the ability of claims-based risk stratification to predict patients' functional status. Second, the time lag inherent in any database-driven instrument such as the administrative proxy precludes its use as a screening tool for new members of a health plan. Our validation study required a full year's continuous membership for calculation of an administrative proxy score. Third, this analysis required the combination of information from multiple databases. Within Health Partners, this task is much simpler due to a unique identifier assigned to each patient; however, a significant number of dual-eligible patients do have split coverage such that one provider manages their Medicare benefits and a second manages their Medicaid benefits. In this case, calculation of an administrative proxy is not possible. Fourth, the AUCs and sensitivities of both the survey Pra and administrative proxy continue to leave substantial room for improvement. Fifth, the Philadelphia Medicare/Medicaid population may not be generalizable. Medicaid members in this region must choose from one of four health maintenance organizations, and benefit shopping occurs. To the extent that Health Partners' package of benefits and perceived service differs from that of its competitors, it may attract a unique population of patients, thus limiting the application of these findings to other dual-eligible populations. Finally, the costs of false positives and false negatives are impossible to assess at this point.
The common response to identification of high-risk patients in a managed care organization is to begin intensive case management of these members. Studies of these interventions in elders have met with mixed results thus far. While some targeted case management programs have been shown to reduce expenditures by decreasing hospitalizations, a recent social worker-based case management program failed to show reductions in health care costs for seniors. 26±28 Thus, although one might hypothesize that the cost of a false negative could be high in terms of increased morbidity and mortality, the cost of a false positive could also be high in exposing patients to increased testing and interventions without improving outcomes or quality of life. Given that the relative cost of false positive and false negative assessments is unknown, we cannot determine the optimal operating point on a receiver operating characteristic curve. Despite these limitations, the administrative proxy discriminated between groups of high and lower resource utilizers over a shorter follow-up period than Coleman et al.'s work and worked equally well in the 50% of Medicaid patients unwilling or unable to respond to survey-based screening. This finding is particularly important in the Medicaid population in which transiency, lower literacy rates, and mistrust of the health system already create significant barriers to health care access. Despite its time lag, if the administrative proxy maintains this performance, it presents an opportunity to identify frail managed care members at minimal incremental cost. In addition, continuous calculation of the risk score may allow more timely intervention for patients whose risk scores change dramatically even in the absence of a full year of data. 
